GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies

Clinical trial NCT00426205 · COMPLETED

Trial details

NCT number: NCT00426205
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Myelodysplastic Syndrome RAEB-I or RAEB-II Refractory Acute Myeloid Leukemia Refractory CML Myeloid Blast Crisis

Start date: 2004-06-01
Primary completion: 2007-09-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.